HPV test for oral cancers may improve patient outcomes and treatments

A new test designed to classify tonsil and throat cancers into one of two groups should help deliver the right treatment to the right patients. A new test designed to classify tonsil and throat cancers into one of two groups should help deliver the right treatment to the right patients.

3 November 2012

Fear, anxiety and embarrassment stop women going for breast screening

Fear, anxiety and embarrassment are some of the main barriers preventing women from going for breast screening, but this alone does not account for the variations in uptake, according to new work presented today at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool today (Wednesday). Fear, anxiety and embarrassment are some of the main barriers preventing women from going for breast screening, but this alone does not account for the variations in uptake, according to new work presented today at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool today (Wednesday).

9 November 2011

Class of breast cancer drugs could treat other types of cancer

A class of drugs used to treat breast cancers which overproduce a protein called HER2 could also treat other types of cancer - particularly head and neck cancers, according to research presented at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool this week. A class of drugs used to treat breast cancers which overproduce a protein called HER2 could also treat other types of cancer - particularly head and neck cancers, according to research presented at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool this week.

9 November 2011

Bowel screening reduces cancer deaths by more than 25 per cent

Bowel screening reduces the number of deaths from bowel cancer in Scotland by more than 25 per cent, according to research presented at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool this week. Bowel screening reduces the number of deaths from bowel cancer in Scotland by more than 25 per cent, according to research presented at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool this week.

9 November 2011

• Health & Medicine

Medics miss key opportunities to prevent cancers linked to obesity

People who work in health care are failing to give patients crucial information about the link between obesity and cancer according to new research presented today (Tuesday) at the National Cancer Research Institute Cancer Conference (NCRI) in Liverpool. People who work in health care are failing to give patients crucial information about the link between obesity and cancer according to new research presented today (Tuesday) at the National Cancer Research Institute Cancer Conference (NCRI) in Liverpool.

8 November 2011

Scientists discover nucleoli damage could kill cancer cells

Damaging a cell's nucleolus could destroy cancer cells by increasing levels of the most important tumour prevention protein, p53, reveals research presented at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool, today. Damaging a cell's nucleolus could destroy cancer cells by increasing levels of the most important tumour prevention protein, p53, reveals research presented at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool, today.

8 November 2011

• Health & Medicine

Bowel, oesophageal and pancreatic cancers show biggest improvement in diagnosis time

Research shows that patients are, on average, being diagnosed more quickly for some cancers, offering a better chance of successful outcome. Research shows that patients are, on average, being diagnosed more quickly for some cancers, offering a better chance of successful outcome.

8 November 2011

Researchers recognised by Cancer Research UK prizes

Cancer Research UK yesterday announced the recipients of this year's Cancer Research UK Prizes at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool. Cancer Research UK yesterday announced the recipients of this year's Cancer Research UK Prizes at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool.

7 November 2011

First evidence of new 'druggable' DNA repair target to destroy cancer cells

BLOCKING a key DNA damage repair enzyme, called APE1, could provide a new way to kill cancer cells containing faulty BRCA genes. BLOCKING a key DNA damage repair enzyme, called APE1, could provide a new way to kill cancer cells containing faulty BRCA genes.

7 November 2011

Breast cancer patients lack adequate fertility preservation advice

Women may not receive adequate information on fertility preservation before breast cancer treatment, according to research presented at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool today (Monday). Women may not receive adequate information on fertility preservation before breast cancer treatment, according to research presented at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool today (Monday).

7 November 2011

Poor men more likely to die from bowel cancer

Deprived men are more likely to die from bowel cancer than men from the most affluent section of society, new research presented at the NCRI Cancer Conference in Liverpool this week shows. Deprived men are more likely to die from bowel cancer than men from the most affluent section of society, new research presented at the NCRI Cancer Conference in Liverpool this week shows.

6 November 2011

Cervical cancers rise in young women

The incidence of cervical cancer in women in their 20s has risen by over 40 per cent between 1992 and 2006 in England, despite the overall incidence of cervical cancer dropping by 30 per cent, according to research* that will be presented at the annual National Cancer Research Institute (NCRI) Cancer Conference in Liverpool which starts tomorrow. The incidence of cervical cancer in women in their 20s has risen by over 40 per cent between 1992 and 2006 in England, despite the overall incidence of cervical cancer dropping by 30 per cent, according to research* that will be presented at the annual National Cancer Research Institute (NCRI) Cancer Conference in Liverpool which starts tomorrow.

5 November 2011